The Japanese Society of Toxicologic Pathology has accepted a paper for publication in its upcoming journal. Entitled “Utilizing Novel Telepathology System in Preclinical Studies and Peer Review”, the paper describes the use of Augmentiqs real-time telepathology in pre-clinical studies involving non-U.S. sponsors performing studies at CROs in the U.S.
Click here to view the advanced publication at JStage.
Augmentiqs is a solution for microscope-based digital pathology. Our technology enables pathology labs to reduce costs and increase clinical excellence.